Skip to content

Member

Margarita DE LA PISA CARRIÓN

Patriots · Spain

Group
Patriots PfE
Country
Spain
Roll-call participation
99.1 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
81.9 %ⓘ of 5 856 votes where the group had a line · Patriots median 82.7 %
More facts (5)
National party
VOX
In office
Since 16 Jul 2024
Against clear line
434 of 4 650 votesⓘ
Committees
EMPL, ENVI (substitute), FEMM, SANT, TRAN (substitute)
Member id
204414
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

99.1 %

5 877 of 5 928 roll calls while in office

Patriots median: 91.1 % (+8.0 pts)

Chamber median: 90.2 %

With majority line ⓘ

81.9 %

4 796 of 5 856 votes where their group had a line

Patriots median: 82.7 % (−0.8 pts)

Against clear line ⓘ

9.3 %

434 of 4 650 votes where their group had a clear line

162 opposite (for ↔ against), 206 abstained against the line, 66 voted for or against when the line was to abstain

Abstention ⓘ

9.4 %

554 of 5 877 votes cast

Participation 99.1 % — Patriots median 91.1 %, 89 members.ⓘ
Data as a table
Participation among the 89 members of the Patriots with enough votes.
FigureParticipation
Margarita DE LA PISA CARRIÓN99.1 %
Patriots median91.1 %
Lowest in the group44.5 %
Highest in the group99.9 %
Members89
With majority line 81.9 % — Patriots median 82.7 %, 89 members.ⓘ
Data as a table
With majority line among the 89 members of the Patriots with enough votes.
FigureWith majority line
Margarita DE LA PISA CARRIÓN81.9 %
Patriots median82.7 %
Lowest in the group72.5 %
Highest in the group92.9 %
Members89
  • Whole term, 5 928 roll-call votes. The dots are the other members of Patriots; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: Abstained ≠ groupMajority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: Against Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: Abstained ≠ groupMajority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: Against Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: Against Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: Against Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: Against ≠ groupMajority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: Abstained Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: Against Majority line: Against
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: Abstained ≠ groupMajority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: Abstained Majority line: Tie
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: Against Majority line: Abstained
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 2 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 2024232
18 Jul 202411
16 Sept 202422
18 Sept 202422
19 Sept 20249292
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202422
22 Oct 20241010
23 Oct 2024129128
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202422
26 Nov 20241818
27 Nov 20241111
28 Nov 20245757
17 Dec 20241313
18 Dec 20243333
19 Dec 20244545
20 Jan 202520
21 Jan 202510
22 Jan 202522
23 Jan 20254544
10 Feb 202511
11 Feb 20253232
12 Feb 20251010
13 Feb 20253030
10 Mar 202522
11 Mar 202599
12 Mar 2025228225
13 Mar 20252424
31 Mar 202533
1 Apr 20253535
2 Apr 2025251250
3 Apr 20256262
5 May 202555
6 May 20251010
7 May 2025220220
8 May 2025103103
21 May 202522
22 May 20255352
16 Jun 202522
17 Jun 20254141
18 Jun 20259191
19 Jun 20258787
7 Jul 202511
8 Jul 20255555
9 Jul 2025134134
10 Jul 20253636
8 Sept 202511
9 Sept 2025101101
10 Sept 20253434
11 Sept 20256969
6 Oct 202522
7 Oct 202555
8 Oct 20255555
9 Oct 20256564
20 Oct 202533
21 Oct 20251313
22 Oct 2025186181
23 Oct 20255555
13 Nov 2025267266
24 Nov 202533
25 Nov 20257574
26 Nov 2025100100
27 Nov 2025125125
15 Dec 202544
16 Dec 20256666
17 Dec 20254343
18 Dec 20254242
20 Jan 20266767
21 Jan 2026112112
22 Jan 20265858
9 Feb 202622
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141141
24 Feb 20264343
9 Mar 202611
10 Mar 2026197196
11 Mar 20266060
12 Mar 20263434
25 Mar 202633
26 Mar 20266969
27 Apr 202622
28 Apr 2026225225
29 Apr 2026296296
30 Apr 20266862
18 May 202644
19 May 202633
20 May 20269696
21 May 20269898
15 Jun 202622
16 Jun 20264040
17 Jun 2026127127
18 Jun 20267777
6 Jul 202622
7 Jul 20267270
8 Jul 2026144142
9 Jul 20266766
14 Sept 202611
15 Sept 2026155155
16 Sept 20268080
17 Sept 2026124124

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within Patriots

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Jorge BUXADÉ VILLALBA PatriotsSpain100 % of 5 602 shared74 %
Mireia BORRÁS PABÓN PatriotsSpain100 % of 5 502 shared74 %
Juan Carlos GIRAUTA VIDAL PatriotsSpain99 % of 5 240 shared74 %
Jorge MARTÍN FRÍAS PatriotsSpain99 % of 4 517 shared74 %
Hermann TERTSCH PatriotsSpain97 % of 4 421 shared74 %
Tiago MOREIRA DE SÁ PatriotsPortugal83 % of 5 619 shared74 %
Anna BRYŁKA changed group PatriotsPoland81 % of 5 191 shared74 %
Vilis KRIŠTOPANS PatriotsLatvia81 % of 5 379 shared74 %
Tomasz BUCZEK changed group PatriotsPoland80 % of 5 379 shared74 %
António TÂNGER CORRÊA PatriotsPortugal80 % of 4 993 shared74 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Guillaume PELTIER ECRFrance80 % of 5 083 shared68 %
Laurence TROCHU ECRFrance80 % of 5 635 shared68 %
Marion MARÉCHAL ECRFrance79 % of 5 035 shared68 %
Nicolas BAY ECRFrance78 % of 5 302 shared68 %
Sarah KNAFO ESNFrance77 % of 4 406 shared70 %
Stephen Nikola BARTULICA ECRCroatia77 % of 4 924 shared68 %
Roberto VANNACCI changed group ESNItaly76 % of 2 244 shared68 %
Jaak MADISON ECREstonia76 % of 4 856 shared68 %
Tobiasz BOCHEŃSKI ECRPoland75 % of 5 127 shared68 %
Waldemar BUDA ECRPoland75 % of 4 879 shared68 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Employment and Social AffairsEMPL CommitteeMember6 Oct 2025now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Women’s Rights and Gender EqualityFEMM CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Committee on Transport and TourismTRAN CommitteeSubstitute19 Jul 2024now
Delegation to the EU-UK Parliamentary Partnership AssemblyD-UK Joint parliamentary committeeMember19 Sept 2024now
Delegation for relations with AfghanistanD-AF DelegationMember19 Sept 2024now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Christians in the Middle EastIG10-07 Intergroup / working groupMember20 Feb 2025now
Intergroup on DemographyIG10-09 Intergroup / working groupMember27 Jan 2025now

Show all 14 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Boosting skills in the Union – opportunities for vocational education and training in times of transitionShadow rapporteur for an opinionFEMM3 Jul 2026
Digital and AI opportunities, challenges for gender equality and gender-based violence including AI-generated contentsShadow rapporteurFEMM3 Jul 2026
No dossier namedOfficial delegationFEMM3 Jul 2026
Boosting skills in the Union – opportunities for vocational education and training in times of transitionShadow rapporteurEMPL29 Jun 2026
Mission to Greenland- FEMM COMMITTEEOfficial delegation29 Jun 2026
The 28th regime corporate legal framework – 'EU Inc.'Shadow rapporteur for an opinionEMPL9 Jun 2026
Establishing a budget expenditure tracking and performance framework and other horizontal rules for the Union programmes and activitiesShadow rapporteur for an opinionFEMM6 May 2026
Public health aspects of biotechnology and life sciencesRapporteurSANT27 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteur for an opinionENVI14 Apr 2026
EP delegation to the Conciliation Committee on Air Passenger Rights 2013/0072(COD)Trilogue negotiator5 Mar 2026

Show all 58 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

72 contributions recorded; 23 on behalf of their group; 100 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (A10-0168/2026 - Loucas Fourlas, Ruggero Razza) (vote) Speech · 1 minRead
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) Speech · 1 minRead
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) Speech · 2 minRead
8 Jul 2026The abduction, forced conversion and child marriage of Maria Shahbaz and the protection of girls in Pakistan Speech · 1 minRead
8 Jul 2026Ongoing persecution of Christians in Nigeria, notably the Kawel village massacre Speech · 1 minRead
6 Jul 2026One-minute speeches on matters of political importance Speech · 1 minRead
18 Jun 2026International Day of Play: promoting children’s right to play (debate) on behalf of PatriotsSpeech · 3 minRead
17 Jun 2026Protecting children’s safety and mental health from the risks posed by social media – our duty to act now (debate) Speech · 1 minRead
20 May 2026Rights, support and protection of victims of crime (debate) on behalf of PatriotsSpeech · 2 minRead
20 May 2026Advancing towards a care society: addressing the gender care gap (debate) on behalf of PatriotsSpeech · 1 minRead

Show all 40 recent contributions

Questions and motions, 71

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
26 Aug 2026Spanish Government plans to transfer illegal immigrants to the mainland P-10-2026-003344Priority written questionwith 5 co-authorsNot yet answered
16 Jul 2026Constitutional coup by Péter Magyar’s government E-10-2026-003035Written questionwith 42 co-authors11 Sept 2026
13 Jul 2026Taking account of the outermost regions’ specific characteristics in the revision of State aid for air transport E-10-2026-002871Written questionwith 10 co-authors2 Sept 2026
3 Jul 2026European Investment Bank funds Morocco’s road and rail networks E-10-2026-002776Written questionwith 5 co-authorsNot yet answered
18 Jun 2026Inclusion of surrogacy in the new EU strategy to combat trafficking in human beings E-10-2026-002535Written questionwith 19 co-authors4 Aug 2026
18 Jun 2026Use of European Social Fund Plus resources to finance abortion, and the definition of healthcare E-10-2026-002536Written questionwith 16 co-authors24 Sept 2026
12 May 2026Commissioner Lahbib’s urgent request to MEPs to lobby for abortion in Member States E-10-2026-001971Written questionwith 5 co-authors29 Jun 2026
11 May 2026Working conditions of lorry drivers in Spain O-10-2026-000024Oral questionNot yet answered
21 Apr 2026Selective penalisation of religious expression in European football and consistency with EU fundamental rights E-10-2026-001627Written questionwith 20 co-authors1 Jul 2026
10 Mar 2026Ethical boundaries regarding abortion policies in Member States in response to My Voice, My Choice E-10-2026-000991Written questionwith 3 co-authors15 Jun 2026

Show all 71 questions and motions

Amendments tabled in committee, 116

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT9
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT10
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ645
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ648
2 Sept 2026Guidelines for the employment policies of the Member States EMPL-AM-792013 EMPL7
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT15
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT20
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT15
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5312
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ531

Show all 116 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Spain National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Margarita DE LA PISA CARRIÓN”. Member record. memberId 204414. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/204414?page=4&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/204414. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/204414?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-204414,
  author = {{EU Parl Watch Research}},
  title = {{Margarita DE LA PISA CARRIÓN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/204414?page=4&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/204414?page=4&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 204414. Official source: https://www.europarl.europa.eu/meps/en/204414. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}